Link to the original source is as follows(might not be available now):
https://drive.infomaniak.com/app/share/475026/4aef7d10-2b2a-49cf-96ef-9dc58795dc59/files/1794
I'm archiving Metabiota emails from Hunter Biden's laptop. There were more than 250 pdf files, but many of them were redundant(multiple files with the same content). I'll try to archive them in chronological order here. Hopefully, those emails could provide a glimpse of what was going on with Hunter Biden and Metabiota.
Metabiota is a pathogen research company associated with Hunter Biden's investment company Rosemont Seneca Partners and also Ukrainina bio-labs. Check my previous posts for more information:
Hunter Biden was involved in Ukrainian bio-labs
Wikipedia deleted entry of Rosemont Seneca Partners, Hunter Biden's company.
Also, Metabiota is one of "2021 Technology Pioneers" selected by the World Economic Forum.
The following emails are from Apr. 16, 2014 to Apr. 17, 2014. I redacted usernames and phone numbers from the original version.
Quarterly Update draft.pdf
From: John DeLoche <(redacted)
Sent: Wednesday, April 16, 2014 at 09:12:17 AM CEST
To: "Hunter Biden" <(redacted)@rosemontseneca.com>, "Devon Archer" <(redacted)@rosemontseneca.com>, "Neil Callahan" <(redacted)@rosemontseneca.com>, "William Lee" <(redacted)
Cc:
Bcc:
Reply-To:
Priority: Low
Subject: Quarterly Update draft
Guys, would like to get a quarterly update out to our LPs this week. Please let me know if you have any comments on this draft:
Dear Limited Partner,
Thank you for being part of our first closing of RSTP II, L.P. Q1 2014 was an active one for the fund. We closed two new investments in Q1, including Counsyl and Metabiota.
Counsyl gives millions of men and women access to vital information about their bodies to make informed choices about their lives. This is a company with which our partnership has significant experience as we invested in their first institutional Series B round from our first fund in 2011. We partnered with Goldman Sachs to lead a secondary investment in Counsyl, increasing our ownership to 5% of the company at an attractive valuation which was in line with the Series C that was completed in August of 2012. We are now the largest outside investor in Counsyl. The company has grown capital efficiently at over a 150% CAGR since our initial investment. We marked up our investment in Counsyl to 1.3x cost to reflect fair market value based on comparable companies the significant progress the company has made since its last financing round.
We also led a first institutional round in Metabiota, a profitable software and services company with significant revenue and growth that develops systems and analytics to mitigate microbial threats. Metabiota is to the USDA what Palantir is to the CIA. The team has spent a decade studying the transmission and spread of disease from animals to humans with customers including the Department of Defence, Department of Homeland Security and other government agencies. They also have customers in the insurance industry who are using Metabiota's data to assess risk to more accurately price insurance policies. We were the only institutional investor allowed in the round and are now helping the company with various business development initiatives to accelerate their growth. We marked our investment in Metabiota up to 1.5x to reflect our inefficiently low entry price, the significant contracts the company has won since our investment and our liquidation preference in the company.
We also launched a new website to more effectively market the fund in Q1. We believe our new website is an impactful representation of our strategy, differentiated team and value add.
in Q1, we retained Troy Investment Associates to assist us in raising the balance or our fund with institutional investors. We are having significant success with these fundraising efforts and expect to meet and potentially exceed our fundraising target of $200 million for RSTP II, L.P. We are enjoying very strong deal flow and are actively engaged in due diligence on multiple potential new investments. We remain vigilant in our deal selection and due diligence process. Please free to reach out to us with any questions.
Best,
The RSTP Team
John
Will
Devon
Neil
Hunter
Rob
EricJohn DeLoche
Co-founder and Managing Director
Rosemont Seneca Technology Partners
333 Bush Street, 21st Floor
San Francisco, CA 94104
office: 415 (redacted)
mobile: 415 (redacted)
This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail.
Fwd_ Talking Points--Business Development Services Team Relentlessly Drives Portfolio Company Growth.pdf
From: John DeLoche <(redacted)@rosemontseneca.com>
Sent: Thursday, April 17, 2014 at 07:48:46 AM CEST
To: "Hunter Biden" <(redacted)@rosemontseneca.com>
Cc:
Bcc:
Reply-To:
Priority: Low
Subject: Fwd: Talking Points--Business Development Services Team Relentlessly Drives Portfolio Company Growth
Hunter,
Here are the talking points by way of reminder. Thanks for joining by video!
Best,
John
Sent from my iPhone
Begin forwarded message:
From: John DeLoche <(redacted)
Date: March 24, 2014 at 3:32:10 PM PDT
To: Hunter Biden <(redacted)@rosemontseneca.com>
Cc: William Lee <(redacted)
Subject: Talking Points--Business Development Services Team Relentlessly Drives Portfolio Company GrowthHunter,
Thanks for taking the time to join us briefly for this meeting with Morgan Stanley.We will likely have already talked about you, Rob and Eric running our Business Development Services Team as a key point of differentiation when we dial you in. It would be great if you could add some more color on the team and differentiation. On your team page we have added that your team's mandate is to "Relentlessly Drive Portfolio Company Growth." I suggest you stress the following:
1. We help our portfolio companies get new customers, both in government and the private sector (Tysons/ Cargills and government agencies in case of Metabiota, Insurance companies as is the case with Counsyl).
2. Public policy is tricky and we help our portfolio companies avoid public policy missteps and take advantage of opportunities-- technology entrepreneurs are often telling us this is a blind spot for them.
3. Driving international growth requires international public policy knowledge and relationships (Counsyl in China and Middle East this year)
We should also stress that your team provides these services free of charge to companies we invest in.
If they ask, you should say that your team is full time on this (which is why you are joining from vacation).
Thanks bro!
John
John DeLoche
Managing Director
Rosemont Seneca Technology Partners
333 Bush Street, 21st Floor
San Francisco, CA 94104
office: 415 (redacted)
mobile: 415 (redacted)This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail.